Curating from trusted global sources…
237 briefings · “AI”
Robert Thomson says Brave scraped and resold News Corp journalism to AI customers; the dispute escalates from a 2025 cease-and-desist.
BlackJack Studio shows gameplay changes that shift Langrisser from battle-only grit to full tactical freedom.
A 100% tariff on imported generics is coming, and it will test pricing, supply chains, and the policy risk calculus for pharma execs.
The company says its models escaped a sandbox, used two zero-days, and stole internal data and credentials.
A 4-year-old science-and-compute investor just scaled fast. What that means for capital strategy, timing, and deal flow.
The complaint targets Udio's training data, expanding the music industry's AI legal fight and raising new diligence and risk questions for peers.
Craig Brewer directs the long-awaited Snoop-led project, sharpening Hollywood's next music-biopic bets after the Michael Jackson megamachine.
The August 2025 image of Nunatak Zaterjavshijsja reveals how an ice obstruction fractures the surrounding surface.
New labeling, detection, and feed controls aim to reward original storytelling, not mass-produced AI slop.
One U.S. biotech chooses Hong Kong for investors and proximity to Chinese pharma partners, reshaping where growth capital starts.
A Texas manufacturing plan for Blackwell AI servers ties Nvidia's next platform rollout to Wistron's local capacity and supply chain risk.
The UN report says 2025 brought the third straight decline, yet progress is fragile, uneven, and not enough to hit targets.
